ACE-031

BIOLOGICAL2 trials

Sponsors

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA

Conditions

Muscle LossMuscular Atrophy

Phase 1

A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 (ActRIIB-IgG1)in Healthy Postmenopausal Volunteers

CompletedNCT00755638

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USAMuscle Loss

Start: 2008-09-30End: 2009-07-31Updated: 2009-07-14

A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 in Healthy Postmenopausal Women

CompletedNCT00952887

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USAMuscular Atrophy

Start: 2009-08-31End: 2011-02-28Updated: 2011-03-23